The incidence of gastroparesis, a disorder that delays or stops food movement within the GI tract, is unsurprising considering that GLP-1 RAs induce weight loss by slowing gastric emptying
Common side effects and contraindications (bullet list): Mild injection-site redness, bruising Increased hunger, flushing, water retention Headache, dizziness, nausea Temporary joint discomfort Contraindications: active cancer, uncontrolled diabetes, pregnancy, certain cardiac conditions Long-Term Effects Long-term use of CJC-1295, either alone or in combination with peptides such as Ipamorelin, may cause persistent changes in hormones impacting reproductive health and aging
The longer estimate (30 days) represents the outer limit
The glutathione (GSH) content was significantly restored, and the histopathological damage in the liver was also significantly improved after rhein treatment
New Formulations: Efforts are underway to create more convenient formulations, including longer-acting injectables that may only require monthly administration and improved oral versions